Genomics (TXG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects ...

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings ...

10x Genomics (TXG) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is ...

Gene sequencing technology company 10x Genomics (NASDAQ: TXG) hasn't been having it easy in the past few days on the stock ...

The average of price targets set by Wall Street analysts indicates a potential upside of 55.9% in 10x Genomics (TXG). While the effectiveness of this highly sought-after metric is questionable, the ...

Detailed price information for 10X Genomics Inc (TXG-Q) from The Globe and Mail including charting and trades.

Wall Street expects a year-over-year increase in earnings on lower revenues when 10x Genomics (TXG) reports results for the quarter ended March 2025. While this widely-known consensus outlook is ...

As you might know, 10x Genomics, Inc. ( NASDAQ:TXG ) just kicked off its latest quarterly results with some very ...

Ladies and gentlemen, thank you so much for standing by and welcome to 10x Genomics First Quarter 2025 Earnings Conference Call. Please note that this call is being recorded. After speakers ...

Travel agency manager Hafizul Hawari applied for a plea bargain at the Sessions Court in Sepang, Selangor, on Monday (May 19) ...